Research progress in synthesis of clopidogrel

Xiandai Huagong/Modern Chemical Industry

Volumn 31, Issue 5, 2011, Pages 30-34

  Wang, Wei ^a   Xue, Ya Ping ^a   Zheng, Yu Guo ^a  

^a ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

(S) clopidogrel; Antiplatelet agent; Asymmetric synthesis; Racemic mixture resolution

Indexed keywords

EID: 79959498251     PISSN: 02534320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Herbert J M, Savi P, Maffrand J P. Biochemical and pharmacological properties of clopidogre: A new ADP receptor antagonist [J]. European Heart Journal, 1999, 20 (Suppl1 A): 31-40.
2. Campo G, Fileti L, Nicoletta de Cesare, et al. Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention [J]. Journal of the American College of Cardiology, 2010, 56: 1447-55.
3. Sanofi S A. Thieno [3, 2-c] pyridine derivatives and their theutic application: US, 4529596 [P]. 1985-07-16.
4. Sanofi. Dextro-rotatory enantiomer of methyl alpha-5 (4, 5, 6, 7-tetrahydro (3, 2-c) thieno pyridyl) (3-chlorophenyl)-aletate and the pharmaceutical compositions containing it: US, 4847265 [P]. 1989-07-11.
5. Kim S D, Kang W, Lee H W, et al. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: A randomized, open label, crossover study in healthy Korean male subjects [J]. Clinical Therapeutics, 2009, 31 (4): 793-803.
6. Sanofi. Process for the preparation of a-bromo-phenylacetic acids: US, 5036156 [P]. 1991-07-30.
7. 2010, 41 (5): 6-7.
8. Sanofi Sa Bakonyi Maria. New Intermediates for clopidogrel and analogs and process for their preparation: WO, 9851681 [P]. 1998-11-19.
9. Wang L X, Shen J F. Synthetic improvements in the preparation of clopidogrel [J]. Organic Process Research & Development, 2007, 11: 487-489.
10. Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel: US, 6800759 [P]. 2004-12-05.
11. Sanofi. 2-Thienylglycidic derivative, process for its preparation and its use as synthesis intermediate: US, 5132435 [P]. 1992-07-21.
12. Hanmi Pharm Co Ltd. Method prepation clopidogrel and intermediates used therein: US, 7763730 [P]. 2010-07-27.
13. Sanofi-Synthelabo. Intermediates and process for the preparation thereof: US, 62150005 [P]. 2001-04-10.
14. SK Chemicals Co Ltd. Process for the preparation of S-(+)-clopidogrel by optical resolution: US, 7696351 [P]. 2010-04-13.
15. Sanofi-Synthelabo. Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates: US, 6573381 [P]. 2003-06-03.
16. 2009, 40 (5): 324-325.
17. Dipharma SPA. Process for the preparation of clopidogrel: US, 7329751 [P]. 2008-02-12.
18. Sanfi SA. Proces for prenaration of N-phenylacetyl derivative of tetrahydrothieno [3, 2-c]pyridine and intermediate of synthesis: EP, 466569 [P]. 1992-01-15.
19. 2009.
20. 2007, 17 (3): 163-165.
21. Sajja E. Process for preparing clopidogrel: US, 20070225320 [P]. 2007-09-27.
22. Lee Pharma Limited. Process for preparation of clopidogrel bisulphate form-1: US, 20070191609 [P]. 2007-08-16.
23. Sanofi. Process for the preparation of an N-phenyl-acetic derivative of tetrahydrothieno (3, 2-c)pyridine and its chemical intermediate: US, 5204469 [P]. 1993-04-20.
24. Sanofi-Synthelabo. Method for preparing 2-thienylethylamine derivatives: US, 6080875 [P]. 2000-07-27.
25. Sanofi-Synthelabo. Process for the preparation of a pharmacologically active substance: US, 6180793 [P]. 2001-01-30.
26. Murakami H. From racemates to single enantiomers chiral synthetic drugs over the last 20 years [J]. Topics in Current Chemistry, 2007, 269: 273-299.
27. IPCA Laboratorles Ltd. Industrial process for preparation of clopidogrel hydrogen sulphate: US, 7629465 [P]. 2009-12-08.
28. Yin L, Shan W J, Jia X, et al. Ru-catalyzed enantioselective preparation of methyl (R)-O-chloromandelate and its application in the synthesis of (S)-Clopidogrel [J]. Journal of Organometallic Chemistry, 2009, 694: 2092-2095.
29. Uhm K N, Lee S J, Kim H K, et al. Enantioselective resolution of methyl 2-chloromandelate by Candida antarctica lipase A in a solvent-free transesterification reaction [J]. Journal of Molecular Catalysis B: Enzymatic, 2007, 45: 34-38.
30. Ferraboschi P, Mieri M D, Galimberti F. Chemo-enzymatic approach to the synthesis of the antithrombotic clopidogrel [J]. Tetrahedron: Asymmetry, 2010, 21: 2136-2141.
31. Daicel Chem. Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same: EP, 1382674 [P]. 2004-01-21.